Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Turcot syndrome × XELOX × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 2 Colorectal Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Colorectal Cancer 1 HER2-positive Colorectal Cancer 1 Gastric Cancer Stage 1 Colonic Neoplasms 1

Interventions

pembrolizumab 3 sintilimab 1 XELOX 1 Surgical Procedures, Operative 1 Nivolumab 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 DEAE-Dextran 1 Colonoscopy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07266025 2026-01-27

CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Turcot syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡